Carboxamides and hydrazide of glycopeptide antibiotic eremomycin were obtained by a direct reaction of the carboxy group of eremomycin with an appropriate amine or hydrazine using diphenyl phosphorazidate as a condencing agent. Eremomycinhydrazide was also obtained by hydrazinolysis of the eremomycinmethyl ester. Use of dicyclohexylcarbodiimide or l-(3-dimethylaminopropyl)-3-ethylcarbodiimide for amidation led to the corresponding eremomycinureides. The ESI-MS data indicate that eremomycinand its amides exist as dimers. The carboxamide, methylamide and benzylamide of eremomycinwere as active against Gram-positive bacteria as the parent antibiotic, and the methylamide, benzylamide and hydrazide were almost an order of magnitude moreactive than eremomycinagainst Staphylococcus epidermidis clinical isolates in vitro. Amideof eremomycinas well as ureides were devoid of histamine liberating properties, which demonstrates that protection of the carboxyl group leads to a decrease in the allergenic properties.
eremomycinas well as ureides were devoid of histamine liberating properties, which demonstrates that protection of the carboxyl group leads to a decrease in the allergenic properties.
Antibiotic eremomycin(1) is a potent antibacterial antibiotic of the dalbaheptide group closely related to vancomycin1}. The molecular basis for the antibacterial activity of the group arises from the specific binding of the glycopeptide to the nascent bacterial cellwall bearing the C-terminal sequence D-Ala-D-Ala. Although the affinity of these antibiotics for the bacterial cell wall analogues in some cases correlates directly with the in vitro antibiotic activity, eremomycin , which is more active than vancomycin against a range of staphylococcal strains, has a lower affinity for the cell wall analogue di-7V-acetyl-L-Lys-D-Ala-D-Ala.
Recently it was demonstrated that eremomycin forms stable dimers (Kdim 3 x 106, for vancomycin Kdim 700) and that the dimerization plays a role in the mechanismof action of these antibiotics2'3). This peculiarity of eremomycin makes investigation of structure-activity relationships among eremomycin derivatives both of practical and theoretical interest.
The model of the eremomycin dimer formation and interaction with the D-Ala-D-Ala moiety suggests that the carboxyl group of the antibiotic participates neither in the dimerization nor in the interaction with the target and thus affords an opportunity for valuable chemical modifications. Eremomycin analogs modified at the FEB. 1996 carboxyl group mayretain the antibacterial properties, whereas the modification mayfavorably influence other pharmacological properties, first of all, allergenicity. Methyl ester of eremomycin (2) CH3COONH4with a linear pH gradient (pH 6.7->9.5).
The fractions containing 4 were acidified with 6 n H2SO4 to pH 6 and desalted by stirring with XAD-resin (50ml) for 24 hours followed by elution with 150ml of H2O-CH3OH(1 : 1) mixture. The eluate was concentrated to a small volume (about 2ml) in vacuo at 50°C and 100ml of acetone was added. The precipitate formed was collected, washed with acetone and dried in vacuo at 20°C overnight to give 39mg (23%) of 4. Rf 0.14 (A); 0.62 (B), 0.42 (C). Ei%m40 (280nm).
[<x]£°-100°(c 1, water).
Eremomycin Hydrazide (5) A. 5 was obtained from 1 and NH2NH2 HC1
similarly to 4 in 20% yield. B. Hydrazine hydrate (0.04ml, 0.6mmol) was added to a stirred solution of83mg (0.05mmol) of2 in 5ml of methane!. After 5 hours at 37°C, the formed precipitate was filtered off, washed with methanol and dried in vacuo. The purification was performed as described for 4 to give Eremomycin Methylamide (6) DPPA (0.043ml, 0.2mmol) was added to a stirred solution of 165mg (0.1 mmol) of1 in 8ml ofDMSO and 0.05 ml of 30% aqueous CH3NH2.The reaction mixture was stirred for 8 hours at 20°C, and another portion (0.043 ml) ofDPPA and 0.1 ml of30% aqueous CH3NH2 were added. After 14 hours of stirring, additional 0.086 ml of DPPAwas added, and in 20 hours the product was precipitated with 150ml of acetone. Purification was performed as described for 4 to yield 33mg (20%) of 6.
Comparison of the XHNMRspectra of 6 and eremomycin demonstrates the presence of a six-proton singlet at 2.86ppm, which corresponds to two methyl groups (TV-terminal and methylamide ones Eremomycin 4-Methylpiperazide (8) It was obtained as described above in 18% yield. In XHNMRspectrum of 8 three-proton singlet of N-Me group and signals offour CH2groups at 4.10-3.37 and 3.15-2.90ppm are present. Rf0.23 (A); 0.57 (C). E4 0 (280nm).
[a]js°-101°(c 1, water for eremomycin) were given to rats. Each group consisted of 6~10 white rats weighting 110~130g each. The stomach was opened 2~3 hours later after administration of the drugs. Intensity of changing of stomach mucosa was macroscopically marked in four ball system and was also investigated hystologically. Hemorrhages and ulcers were marked with four balls if they covered 5O~85%of stomach mucosa. Three balls correspond to changes of 30~50% of surface and two balls to 10~30%, smaller changes were marked with one ball.
( Table  3 ).
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